PL1953161T3 - Nowe tricykliczne pochodne, sposób ich wytwarzania i kompozycje farmaceutyczne zawierające te pochodne - Google Patents

Nowe tricykliczne pochodne, sposób ich wytwarzania i kompozycje farmaceutyczne zawierające te pochodne

Info

Publication number: PL1953161T3
Authority: PL; Poland
Prior art keywords: pharmaceutical compositions; compositions containing; preparing same; tricyclic derivatives; new tricyclic
Prior art date: 2007-02-02

Application number

PL08290088T

Other languages

English (en)

Inventor

Patrick Casara

Diguarher Thierry Le

Olivier Geneste

John Hickman

Original Assignee

Servier Lab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-02-02

Filing date

2008-02-01

Publication date

2010-01-29

2008-02-01 Application filed by Servier Lab filed Critical Servier Lab

2010-01-29 Publication of PL1953161T3 publication Critical patent/PL1953161T3/pl

Links

239000008194 pharmaceutical composition Substances 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Oncology (AREA)
Engineering & Computer Science (AREA)
Hematology (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Indole Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

PL08290088T 2007-02-02 2008-02-01 Nowe tricykliczne pochodne, sposób ich wytwarzania i kompozycje farmaceutyczne zawierające te pochodne PL1953161T3 (pl)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR0700741A FR2912145B1 (fr)	2007-02-02	2007-02-02	Nouveaux derives tricycliques,leur procede de preparation et les compositions pharmaceutiques qui les contiennent
EP08290088A EP1953161B1 (fr)	2007-02-02	2008-02-01	Nouveaux dérivés tricycliques, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number	Publication Date
PL1953161T3 true PL1953161T3 (pl)	2010-01-29

Family

ID=38219469

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL08290088T PL1953161T3 (pl)	2007-02-02	2008-02-01	Nowe tricykliczne pochodne, sposób ich wytwarzania i kompozycje farmaceutyczne zawierające te pochodne

Country Status (45)

Country	Link
US (1)	US20080188460A1 (pl)
EP (1)	EP1953161B1 (pl)
JP (1)	JP2008266296A (pl)
KR (1)	KR100997027B1 (pl)
CN (1)	CN101270120A (pl)
AP (1)	AP2009004945A0 (pl)
AR (1)	AR065131A1 (pl)
AT (1)	ATE440842T1 (pl)
AU (1)	AU2008200499A1 (pl)
BR (1)	BRPI0800988A2 (pl)
CA (1)	CA2619897C (pl)
CL (1)	CL2008000318A1 (pl)
CO (1)	CO6230990A2 (pl)
CR (1)	CR10953A (pl)
CY (1)	CY1109637T1 (pl)
DE (1)	DE602008000104D1 (pl)
DK (1)	DK1953161T3 (pl)
EA (1)	EA014672B1 (pl)
EC (1)	ECSP099546A (pl)
ES (1)	ES2332337T3 (pl)
FR (1)	FR2912145B1 (pl)
GE (1)	GEP20115186B (pl)
GT (1)	GT200900217A (pl)
HR (1)	HRP20090565T1 (pl)
IL (1)	IL200128A0 (pl)
JO (1)	JO2616B1 (pl)
MA (1)	MA29725B1 (pl)
MX (1)	MX2008001504A (pl)
MY (1)	MY144633A (pl)
NI (1)	NI200900147A (pl)
NZ (1)	NZ565643A (pl)
PA (1)	PA8768301A1 (pl)
PE (1)	PE20081703A1 (pl)
PL (1)	PL1953161T3 (pl)
PT (1)	PT1953161E (pl)
RS (1)	RS51133B (pl)
SA (1)	SA08290043B1 (pl)
SG (1)	SG144892A1 (pl)
SI (1)	SI1953161T1 (pl)
SV (1)	SV2009003348A (pl)
TN (1)	TN2009000307A1 (pl)
TW (1)	TW200838532A (pl)
UA (1)	UA90726C2 (pl)
WO (1)	WO2008110691A1 (pl)
ZA (1)	ZA200801103B (pl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2498519T3 (es)	2006-09-07	2014-09-24	F. Hoffmann-La Roche Ag	Un procedimiento para la fabricación de SNAC (SALCAPROZATO SÓDICO)
FR2933983B1 (fr) *	2008-07-15	2010-08-27	Servier Lab	Nouveaux derives tricycliques,leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
US8518933B2 (en) *	2009-04-23	2013-08-27	Abbvie Inc.	Modulators of 5-HT receptors and methods of use thereof
US8546377B2 (en) *	2009-04-23	2013-10-01	Abbvie Inc.	Modulators of 5-HT receptors and methods of use thereof
EP2421870B1 (en) *	2009-04-23	2016-03-09	AbbVie Inc.	Modulators of 5-ht receptors and methods of use thereof
CA2772989A1 (en) *	2009-09-10	2011-03-17	Novartis Ag	Sulfonamides as inhibitors of bcl-2 family proteins for the treatment of cancer
CN102584744B (zh) *	2011-01-06	2015-07-01	上海药明康德新药开发有限公司	4-(4-((2-(4-氯苯基)-5,5-二甲基环己基-1-烯)甲基)哌嗪-1-基)苯甲酸的合成方法
US8946445B2 (en)	2011-10-12	2015-02-03	Nanjing Allgen Pharma Co., Ltd.	Heterocyclic molecules as apoptosis inducers
TWI620733B (zh)	2013-05-21	2018-04-11	拜耳作物科學股份有限公司	製備特定肟類及肟醚類之改良方法
JOP20190239A1 (ar)	2017-04-19	2019-10-09	Neurocrine Biosciences Inc	مركبات مثبطة لـ vmat2 وتركيبات منها

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3899490A (en) *	1968-01-12	1975-08-12	Pfizer	Hexahydro pyrazinoquinolines
DE2362539C2 (de) *	1973-12-17	1986-05-07	Merck Patent Gmbh, 6100 Darmstadt	2-Acyl-4-oxo-1,2,3,6,7,11b-hexahydro-4H-pyrazino[2,1-a]isochinoline, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
US5688950A (en) *	1996-04-23	1997-11-18	Neurogen Corporation	Tricyclic aminoalkylcarboxamides; novel dopamine D3 receptor subtype specific ligands
JP2000169475A (ja) *	1998-07-24	2000-06-20	Dai Ichi Seiyaku Co Ltd	ピラゾ―ル誘導体およびその塩
US6180629B1 (en) *	1998-08-14	2001-01-30	Cell Pathways, Inc.	[4,5]-Fused-1,3-disubstituted-1,2-diazine-6-one derivatives with nitrogen containing substitutents in position one for the treatment of neoplasia
US6190629B1 (en)	1999-04-16	2001-02-20	Cbl Technologies, Inc.	Organic acid scrubber and methods
US7919493B2 (en) *	2000-04-12	2011-04-05	Pharma Mar, S.A.	Anititumoral ecteinascidin derivatives
WO2002010169A1 (en) *	2000-07-31	2002-02-07	F. Hoffmann-La Roche Ag	Piperazine derivatives
DE60231230D1 (de) *	2001-11-03	2009-04-02	Astrazeneca Ab	Quinazolin derivate als antitumor-mittel
WO2003059353A1 (en) *	2001-12-21	2003-07-24	King Pharmaceuticals Research And Development, Inc.	Tyrosyl derivatives and their use as p2x7 receptor modulators
FR2841243B1 (fr) *	2002-06-19	2004-08-20	Servier Lab	Nouveaux derives de 3-(4-oxo-4h-chromen-2yl)-(1h)-quinolein- 4-ones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US7135480B2 (en) *	2002-12-12	2006-11-14	Cytovia, Inc.	Substituted 1-benzoyl-3-cyano-pyrrolo [1,2-a] quinolines and analogs as activators of caspases and inducers of apoptosis
WO2005049593A2 (en) *	2003-11-13	2005-06-02	Abbott Laboratories	N-acylsulfonamide apoptosis promoters
ES2564804T3 (es) *	2004-02-12	2016-03-29	Mitsubishi Tanabe Pharma Corporation	Compuesto de indazol y uso farmacéutico del mismo
US7790712B2 (en) *	2005-03-17	2010-09-07	Boehringer Ingelheim Pharmaceutical, Inc.	Substituted [1,4]diazepino[1,2-A]indoles and azepino[1,2-A]indoles as anti-cytokine inhibitors
EP2249818A4 (en) *	2008-02-12	2011-09-07	Univ Stanford	ANTAGONISTS OF THE HEDGEHOG PATHWAY AND METHODS OF USE

2007
- 2007-02-02 FR FR0700741A patent/FR2912145B1/fr not_active Expired - Fee Related
2008
- 2008-01-23 PE PE2008000167A patent/PE20081703A1/es not_active Application Discontinuation
- 2008-01-24 US US12/011,225 patent/US20080188460A1/en not_active Abandoned
- 2008-01-28 GE GEAP200810489A patent/GEP20115186B/en unknown
- 2008-01-28 MY MYPI20080152A patent/MY144633A/en unknown
- 2008-01-28 MA MA30601A patent/MA29725B1/fr unknown
- 2008-01-29 UA UAA200801063A patent/UA90726C2/ru unknown
- 2008-01-30 SA SA08290043A patent/SA08290043B1/ar unknown
- 2008-01-31 SG SG200800896-3A patent/SG144892A1/en unknown
- 2008-01-31 MX MX2008001504A patent/MX2008001504A/es active IP Right Grant
- 2008-01-31 BR BRPI0800988-0A patent/BRPI0800988A2/pt not_active IP Right Cessation
- 2008-02-01 SI SI200830004T patent/SI1953161T1/sl unknown
- 2008-02-01 PT PT08290088T patent/PT1953161E/pt unknown
- 2008-02-01 PL PL08290088T patent/PL1953161T3/pl unknown
- 2008-02-01 DK DK08290088T patent/DK1953161T3/da active
- 2008-02-01 EA EA200800235A patent/EA014672B1/ru not_active IP Right Cessation
- 2008-02-01 TW TW097104070A patent/TW200838532A/zh unknown
- 2008-02-01 AR ARP080100421A patent/AR065131A1/es unknown
- 2008-02-01 DE DE602008000104T patent/DE602008000104D1/de active Active
- 2008-02-01 JP JP2008022515A patent/JP2008266296A/ja active Pending
- 2008-02-01 RS RSP-2009/0449A patent/RS51133B/sr unknown
- 2008-02-01 EP EP08290088A patent/EP1953161B1/fr active Active
- 2008-02-01 CA CA2619897A patent/CA2619897C/fr not_active Expired - Fee Related
- 2008-02-01 PA PA20088768301A patent/PA8768301A1/es unknown
- 2008-02-01 AT AT08290088T patent/ATE440842T1/de active
- 2008-02-01 WO PCT/FR2008/000121 patent/WO2008110691A1/fr active Application Filing
- 2008-02-01 ES ES08290088T patent/ES2332337T3/es active Active
- 2008-02-01 AU AU2008200499A patent/AU2008200499A1/en not_active Abandoned
- 2008-02-01 ZA ZA200801103A patent/ZA200801103B/xx unknown
- 2008-02-01 NZ NZ565643A patent/NZ565643A/en unknown
- 2008-02-01 KR KR1020080010639A patent/KR100997027B1/ko not_active Expired - Fee Related
- 2008-02-01 CL CL200800318A patent/CL2008000318A1/es unknown
- 2008-02-01 AP AP2009004945A patent/AP2009004945A0/xx unknown
- 2008-02-02 JO JOP/2008/0039A patent/JO2616B1/ar active
- 2008-02-02 CN CNA2008100963808A patent/CN101270120A/zh active Pending
2009
- 2009-07-23 TN TNP2009000307A patent/TN2009000307A1/fr unknown
- 2009-07-24 CR CR10953A patent/CR10953A/es unknown
- 2009-07-28 EC EC2009009546A patent/ECSP099546A/es unknown
- 2009-07-28 IL IL200128A patent/IL200128A0/en unknown
- 2009-07-29 NI NI200900147A patent/NI200900147A/es unknown
- 2009-07-31 SV SV2009003348A patent/SV2009003348A/es unknown
- 2009-07-31 CO CO09080210A patent/CO6230990A2/es not_active Application Discontinuation
- 2009-07-31 GT GT200900217A patent/GT200900217A/es unknown
- 2009-10-22 HR HR20090565T patent/HRP20090565T1/hr unknown
- 2009-11-24 CY CY20091101213T patent/CY1109637T1/el unknown

Also Published As

Publication number	Publication date
RS51133B (sr)	2010-10-31
EA200800235A1 (ru)	2008-08-29
CL2008000318A1 (es)	2008-08-08
EA014672B1 (ru)	2010-12-30
NZ565643A (en)	2009-05-31
TN2009000307A1 (fr)	2010-12-31
KR20080072574A (ko)	2008-08-06
ECSP099546A (es)	2009-08-28
KR100997027B1 (ko)	2010-11-25
SA08290043B1 (ar)	2011-06-22
EP1953161B1 (fr)	2009-08-26
FR2912145A1 (fr)	2008-08-08
US20080188460A1 (en)	2008-08-07
CA2619897A1 (fr)	2008-08-02
ZA200801103B (en)	2008-12-31
MX2008001504A (es)	2009-02-24
CY1109637T1 (el)	2014-08-13
UA90726C2 (ru)	2010-05-25
PE20081703A1 (es)	2009-01-14
JP2008266296A (ja)	2008-11-06
FR2912145B1 (fr)	2009-03-06
SV2009003348A (es)	2010-02-01
IL200128A0 (en)	2010-04-15
DK1953161T3 (da)	2009-11-30
SI1953161T1 (sl)	2009-12-31
JO2616B1 (ar)	2011-11-01
PT1953161E (pt)	2009-10-26
ATE440842T1 (de)	2009-09-15
AR065131A1 (es)	2009-05-20
SG144892A1 (en)	2008-08-28
MY144633A (en)	2011-10-14
BRPI0800988A2 (pt)	2008-11-25
EP1953161A1 (fr)	2008-08-06
GT200900217A (es)	2011-09-14
CA2619897C (fr)	2011-06-14
CO6230990A2 (es)	2010-12-20
DE602008000104D1 (de)	2009-10-08
ES2332337T3 (es)	2010-02-02
CR10953A (es)	2009-09-09
AU2008200499A1 (en)	2008-08-21
GEP20115186B (en)	2011-03-25
CN101270120A (zh)	2008-09-24
PA8768301A1 (es)	2008-11-19
TW200838532A (en)	2008-10-01
HRP20090565T1 (hr)	2009-12-31
AP2009004945A0 (en)	2009-08-31
WO2008110691A1 (fr)	2008-09-18
MA29725B1 (fr)	2008-09-01
NI200900147A (es)	2010-02-15

Publication	Publication Date	Title
SI1953161T1 (sl)	2009-12-31	Novi tricikliäśni derivati, postopek priprave le-teh in farmacevtski sestavki, ki jih vsebujejo
IL219602A0 (en)	2012-07-31	Tricylic pyrazol amine derivatives, their preparation and pharmaceutical compositions containing them
IL209258A (en)	2017-01-31	Derivatives of Pyrolopyridine, Pharmaceutical Preparations Containing Them, Processes for their Preparation and Uses
IL205043A (en)	2015-07-30	Phenylamide and pyridylamide derivatives, pharmaceutical preparations containing them, method of preparation and use thereof
HK1164050A1 (en)	2012-09-21	Substituted azoanthracene derivatives, pharmaceutical compositions, and methods of use thereof
IL203142A (en)	2015-02-26	Anti-B antibody CD79, pharmaceuticals including them, their use and method of preparation
IL196280A0 (en)	2009-09-22	Use of ampk-activating imidazole derivatives, preparation process therefor and pharmaceutical compositions comprising them
HK1164292A1 (en)	2012-09-21	Novel tricyclic derivative or pharmaceutically acceptable salts thereof, preparation method thereof, and pharmaceutical composition containing the same
SI2107055T1 (sl)	2011-05-31	Derivati diosmetina, postopek za njihovo pripravo in njihovi farmacevtski sestavki
HK1154868A1 (en)	2012-05-04	Cholest-4-en-3-one oxime derivatives, pharmaceutical compositions containing same, and preparation method -4--3-
SI2036892T1 (sl)	2010-06-30	Derivati tetrahidro h benzazepinov postopek za njihovo pripravo in farmacevtski sestavkiki jih vsebujejo
HUP0600809A2 (en)	2008-08-28	New phenylsulfamoyl-benzamide derivatives as bradykinin antagonists, process and intermediates for their preparation and pharmaceutical compositions containing them
SI2281822T1 (sl)	2013-04-30	Novi derivati dihidroindolona, postopek za njihovo pripravo in farmacevtski sestavki, ki jih vsebujejo
IL210377A (en)	2015-03-31	History of Naphthyridone, their preparation and their pharmaceutical preparations
IL205710A (en)	2013-07-31	History of Spiro [Pipyridine-Benzopyran] Pharmaceuticals Containing Them, Methods of Preparing and Using Their @
IL207263A0 (en)	2010-12-30	Tricyclic pyridine derivatives, medicaments containing such compounds, their use and process for their preparation
SI2231598T1 (sl)	2011-11-30	Novi derivati diazeniumdiolata postopek pripravele teh in njihovi farmacevtski sestavki
SI2147915T1 (sl)	2010-11-30	Novi cikloalkilirani benzotiadiazinski derivati postopek za njihovo pripravo in farmacevtski sestavki ki jih vsebujejo
PL1873140T3 (pl)	2010-01-29	Nowe pochodne naftalenowe, sposób ich wytwarzania i kompozycje farmaceutyczne je zawierające
IL213588A0 (en)	2011-07-31	Naphthyridine derivatives, their preparation and pharmaceutical compositions containing them
IL213792A0 (en)	2011-07-31	Novel oxime derivatives of 3, 5-seco-4-nor-cholestane, pharmaceutical compositions containing the same and method for preparing the same
ZA201005316B (en)	2011-10-26	2-amino-2-phenyl-alkanol derivatives, their preparation and pharmaceutical compositions containing them
EP2222624A4 (en)	2012-04-18	4-NEROLIDYLCATECHOL DERIVATIVES, PHARMACEUTICAL COMPOSITIONS COMPRISING THESE DERIVATIVES AND PREPARATION METHOD THEREOF
EP2565180A4 (en)	2014-02-05	ALPHA-ARYLMETHOXYACRYLATE DERIVATIVE PRODUCTION METHOD AND PHARMACEUTICAL COMPOSITION THEREWITH
ZA201003335B (en)	2011-09-28	Cephalomannine derivatives and their preparation,medicinal composition and use